NCT01937234View on ClinicalTrials.gov

Use of an Antiemetic to Shorten the Length of Labor in Nulliparous Women

PHASE4CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

July 31, 2016

Study Completion Date

September 30, 2016

Conditions
Prolonged First Stage of Labor
Interventions
DRUG

Metoclopramide

"Intravenous injection of 10mg metoclopramide, at enrollment, then every 2 hours.~Maximum of 3 doses."

DRUG

Placebo

"Intravenous injection of 0.9% sodium chloride, at enrollment, then every 2 hours.~Maximum of 3 doses."

Trial Locations (1)

101

Labor and delivery ward of Armed Forces Hospital, Southern Region., Khamis Mushait

All Listed Sponsors
collaborator

Armed Forces Hospitals, Southern Region, Saudi Arabia

OTHER_GOV

lead

Ain Shams University

OTHER

NCT01937234 - Use of an Antiemetic to Shorten the Length of Labor in Nulliparous Women | Biotech Hunter | Biotech Hunter